Related Experiment Video
Updated: Apr 11, 2026
07:04
Forskolin-induced Swelling in Intestinal Organoids: An In Vitro Assay for Assessing Drug Response in Cystic Fibrosis Patients
Published on: February 11, 2017
20.3K
SUMOylation Modulates CFTR Biogenesis: Is the Pathway Druggable?
Annette Ahner, Raymond A Frizzell1
1University of Pittsburgh School of Medicine, Department of Cell Biology, 7116 Rangos Research Center, 4401 Penn Avenue, Pittsburgh, PA 15224, USA. frizzell@pitt.edu.
Current Drug Targets
|June 2, 2015
Summary
The SUMOylation pathway regulates cellular functions and is linked to diseases like cancer. Developing targeted SUMOylation inhibitors is a promising therapeutic strategy, particularly for conditions affecting CFTR protein processing.
Area of Science:
- Biochemistry and Molecular Biology
- Cellular Biology
- Drug Discovery
Background:
- The SUMOylation pathway regulates diverse cellular functions, both nuclear and extra-nuclear.
- Components of the SUMOylation pathway are implicated in diseases including cystic fibrosis, cancer, and neurodegenerative disorders.
- Targeting SUMOylation pathways presents a therapeutic opportunity due to their critical roles in disease.
Purpose of the Study:
- To outline the SUMOylation pathway.
- To summarize current drug development efforts targeting SUMOylation pathway components.
- To emphasize the potential impact of SUMOylation on CFTR protein processing.
Main Methods:
- Review of existing literature on SUMOylation pathways and drug development.
- Analysis of the components and mechanisms of SUMOylation.
- Examination of the relationship between SUMOylation and protein processing, specifically CFTR.
Main Results:
- The SUMOylation cascade involves a limited number of components, potentially complicating drug specificity.
- Small molecule inhibitors targeting SUMOylation are in the early stages of development.
- SUMOylation pathway modulation may affect CFTR protein processing.
Conclusions:
- SUMOylation pathway components represent viable therapeutic targets for various diseases.
- Developing specific small molecule inhibitors for SUMOylation is an emerging area of drug development.
- Further research is needed to understand and leverage SUMOylation's role in diseases like cystic fibrosis.
More Related Videos
Related Concept Videos
01:29Pharmacogenomics: Identification of New Drug Targets
91
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
91
01:45Regulation of Nuclear Protein Sorting
3.5K
Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
3.5K
01:23Cystic Fibrosis: Pathogenesis
1.1K
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
1.1K
02:04Covalently Linked Protein Regulators
9.9K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
9.9K
01:23Regulation of Expression at Multiple Steps
1.6K
The gene expression in cells is regulated at different stages: (i) transcription, (ii) RNA processing, (iii) RNA localization, and (iv) translation. Transcriptional regulation is mediated by regulatory proteins such as transcription factors, activators, or repressors—these control gene expression by initiating or inhibiting the transcription of genes. Once a precursor or pre-mRNA is produced, it undergoes post-transcriptional modification, including 5' capping, splicing, and the...
1.6K